Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

164.77
+1.881.15%
Volume:696.97K
Turnover:114.91M
Market Cap:255.56B
PE:24.67
High:165.60
Open:164.52
Low:164.30
Close:162.89
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:1.56
T/O Rate:0.05%
Dividend:3.16
Dividend Rate:1.92%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:5.08
PE(LYR):25.19

Loading ...

Deutsche Bank Keeps Their Sell Rating on AstraZeneca (AZN)

TIPRANKS
·
Jul 28

AstraZeneca Upbeat Internal Pipeline Can Drive Growth Beyond 2030

Dow Jones
·
Jul 28

AstraZeneca (AZN) Gets a Buy from Barclays

TIPRANKS
·
Jul 28

Goldman Sachs Reaffirms Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Jul 28

AstraZeneca Beats Q2 Core Earnings Forecast, Reaffirms $80 Billion Revenue Goal for 2030

Deep News
·
Jul 28

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Jul 28

Top Midday Stories: Nvidia Enters Into $500 Billion Partnership With SK Group; AstraZeneca Earnings Top Estimates

MT Newswires Live
·
Jul 27

AstraZeneca Posts 6% Revenue Growth in First Half, Maintains Full-Year Forecast

Deep News
·
Jul 27

AstraZeneca miss ‘clear positive’ for Omeros, says H.C. Wainwright

TIPRANKS
·
Jul 27

Omeros up 11% to $10.89 after AstraZeneca study failure

TIPRANKS
·
Jul 27

AstraZeneca's Sone-Ve Significantly Extends Overall Survival in Late-Stage Gastric Cancer Phase III Trial

Deep News
·
Jul 27

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday as Oil Prices Fall

MT Newswires Live
·
Jul 27

Sector Update: Healthcare

MT Newswires Live
·
Jul 27

Pipeline Speed Bump Doesn't Shake AstraZeneca's $80 Billion Revenue Ambition

Benzinga Earnings
·
Jul 27

AstraZeneca Sees Potential for AI Beyond Drug Discovery

Dow Jones
·
Jul 27

AstraZeneca Wants to Move at 'Chinese Speed,' CEO Says

Dow Jones
·
Jul 27

Europe Faces Competition for Pharma Investment, AstraZeneca CEO Says

Dow Jones
·
Jul 27

Europe, Japan are Falling Behind on Pharma Innovation, AstraZeneca CEO Says

Dow Jones
·
Jul 27

AstraZeneca Sees 2030 Goal on Track as Cancer Drugs Drive Growth

Dow Jones
·
Jul 27

Press Release: AstraZeneca Results: H1 and Q2 2026

Dow Jones
·
Jul 27